viewFastForward Innovations Limited

FastForward says portfolio firm Juvenescence forms joint venture with G3 Therapeutics

The new venture will focus on developing medicines to combat ageing and age-related diseases

FastForward Innovations Limited - FastForward portfolio firm Juvenescence forms joint venture with G3 Therapeutics

FastForward Innovations Ltd (LON:FFWD) said its portfolio firm, Juvenescence has formed a joint venture with biotech firm G3 Therapeutics, called Juvenomics, which will focus on developing medicines to combat ageing and age-related diseases.

The company, which owns a 0.63% stake in Juvenescence, said Juvenomics is built on Juvenescence’s machine learning platforms in combination with G3’s proprietary, multi-omic biological dataset, consisting of trillions of proprietary datapoints collected in the GLOBAL Clinical Study of over 7,500 patients.

WATCH: FastForward Innovations Ltd names new CEO, updates on recent portfolio company achievements

Juvenomics has also appointed David Roblin, the former president of research & development at Summit Therapeutics PLC (NASDAQ:SMMT), head of anti-infectives at Bayer and head of research in Europe at Pfizer Inc (NYSE:PFE), as its chief operating offer.

"At Juvenescence, we are very excited about this opportunity to work with G3. Since its inception Juvenescence has been at the vanguard of applying data science towards drug discovery and development”, Juvenescence founder and chief executive Gregory Bailey said in a statement.

“The depth of the patient-derived database assembled by G3 is extraordinary and compelling. To have exclusive access to the existing data and the new data that G3 generates going forward for anti-ageing and age-related diseases is a unique opportunity. This data gives us the ability to accelerate discovery and development of therapeutics to modify healthy ageing", Bailey added.

Shares in FastForward were steady at 6p in mid-morning trading on Tuesday.

Quick facts: FastForward Innovations Limited

Price: 5.855 GBX

Market: LSE
Market Cap: £9.46 m


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FastForward Innovations Limited named herein, including the promotion by the Company of FastForward Innovations Limited in any Content on the...



FastForward Innovations CEO updates as portfolio firm Yooma agrees reverse...

FastForward Innovations Limited's (LON:FFWD) Ed McDermott caught up with Proactive London's Andrew Scott following the news its portfolio firm Yooma Corp has agreed a reverse takeover with Globalive Technology Inc. Globalive is aiming to acquire Yooma for an aggregate consideration of around...

21 hours, 1 minute ago

2 min read